Skip to main content

Revelation Biosciences, Inc.

corporate_fare Company Profile

Revelation Biosciences, Inc.

REVB·NASDAQ·Life Sciences·CIK 0001810560

Revelation is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company has multiple ongoing programs to evaluate Gemini, including GEM-AKI as a treatment for acute kidney injury (AKI) and GEM-CKD as a treatment for chronic kidney disease (CKD). Revelation was incorporated in Delaware on November 20, 2019, originally as Petra Acquisition, Inc., and is based in San Diego, California. Its common stock and Public Warrants are listed on The Nasdaq Stock Market, LLC (Nasdaq) under the ticker symbols "REVB" and "REVBW," respectively. On June 23, 2025, stockholders granted discretionary authority to the board of directors to amend the certificate of incorporation for reverse stock splits. Following this, a 1-for-3 reverse stock split of outstanding common stock became effective on July 7, 2025. Additionally, a 1-for-4 reverse stock split of outstanding common stock became effective on January 28, 2026.

Revelation Biosciences, Inc. (NASDAQ:REVB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 23 items for REVB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for REVB spans 10-Q, 8-K, DEF 14A, PRE 14A.

Recent high-impact activity:

  • Revelation Cuts Gemini Kidney-Injury Trial Budget to ~$7M From ~$60M
  • Q3 Net Loss Widens to $3.3M as Cash Falls to $9.1M; Runway Into Q2 2027
  • Revelation Biosciences Q3 2026: $9.1M Cash, Going Concern, Nasdaq MVLS Delisting Risk
  • Revelation Biosciences Sets 1-for-7 Reverse Split Effective October 20
  • Revelation Biosciences posts Q2 2026 loss, holds $11.5M cash runway through Q1 2027, and advances pivotal AKI trial

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$8.91M
Diluted EPS
-$23.95
Op. Cash Flow
-$8.27M
Operating Income
-$9.07M
Cash & Equivalents
$10.7M
Debt / Equity
0.00×
Shares Outstanding
1.58M sh
Source: 10-K · filed 2026-02-26 · accession 0001193125-26-076552

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 12,792 shares in REVB as of the October 30, 2026 settlement, a 93.7% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 5.4% of REVB volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)12,792 shares as of October 30, 2026
Change vs prior period▲ 93.7%
Days to cover1.00 at avg daily volume of 39,572
Daily short volume (FINRA facilities)5.4% of 5,066 shares on November 20, 2026
5-day average short volume30.3%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with R →
$3.55 -3.79% today
52-week range · as of 2026-11-05 $3.08 – $40.6
Market cap
$2.39M
Volume
9.8K (0.5× avg)
3-mo avg 20.8K
Live data · 2026-11-22 00:31 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed REVB - Latest Insights

REVB
Nov 16, 2026, 9:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $4.20
Real-time Price: $3.55 info
Change: -$0.650 (-15%) info
Market Cap: $2.392M info
REVB
Nov 05, 2026, 5:29 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $3.56
Real-time Price: $3.55 info
Change: -$0.010 (-0.28%) info
Market Cap: $2.392M info
REVB
Nov 05, 2026, 5:23 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.56
Real-time Price: $3.55 info
Change: -$0.010 (-0.28%) info
Market Cap: $2.392M info
REVB
Oct 16, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.7622
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Aug 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Aug 06, 2026, 4:07 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.12
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Jul 13, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.9869
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Jun 24, 2026, 4:47 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.03
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Jun 01, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
May 11, 2026, 9:56 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $0.916399
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
May 07, 2026, 4:23 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.02
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
May 07, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.02
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Apr 30, 2026, 4:31 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.13
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Mar 30, 2026, 9:00 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $1.18
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Mar 19, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Feb 26, 2026, 4:25 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Feb 26, 2026, 4:06 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $1.33
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Feb 17, 2026, 12:35 PM EST
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $1.49
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Feb 11, 2026, 5:30 PM EST
Filing Type: 424B3
Importance Score:
9
Price at Filing: $1.50
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
REVB
Feb 06, 2026, 4:32 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $3.55 info
Change: Reverse Stock Split info
Market Cap: $2.392M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets